Accessibility Menu
Srx Global logo

Srx Global(NYSEMKT) SRXH

Market Cap$34.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-99%
5 Year-100%
1 Year-93%
1 Month+22%
$1.69
-1.17%
-0.02Today
After hours$1.68-$0.01 (-0.59%)
Srx Global last closing stock price
MetricPriceDate
Last closeUSD 1.682026-08-31
Srx Global stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.18%USD 1.812026-08-24
1 month+21.74%USD 1.382026-07-31
3 month-77.57%USD 7.492026-06-02
Year to date-87.42%USD 13.352025-12-31
1 year-93.13%USD 24.452025-08-29
3 year-99.7%USD 559.212023-09-01
5 year-99.98%USD 9,088.532021-09-01
Since inception-98.58%USD 118.322025-04-25

Srx Global Financials at a Glance

Market Cap

$34.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

-$37.41M

Net Income (TTM)

-$40.42M

EPS (TTM)

$0.00

P/E Ratio

0.01

Dividend

$0.00

Beta (Volatility)

0.70 (Low)

Price

$1.69

Volume

1,945

Open

$1.70

Previous Close

$1.68

Daily Range

$1.62 - $1.71

52-Week Range

$0.94 - $41.56

Estimated Earnings Date

Dec 25, 2026

SRXH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Srx Global

SRX Global Inc. develops artificial intelligence (AI)-powered solutions designed to improve decision-making, streamline operations, and strengthen risk management. Headquartered in Tampa, Florida, the company operates within the technology sector, specifically in software applications.

Products and Services
  • AI-driven software solutions for enhanced decision-making
  • Tools for operational efficiency and risk management
  • Customizable applications tailored to client needs
Growth Outlook
  • Recent quarterly revenue increased to $3.44 million, showing positive momentum
  • Strong cash position with $20.54 million in cash and equivalents
  • Market demand for AI solutions continues to rise, presenting growth opportunities
Financial Highlights
  • Trailing twelve months (TTM) revenue of $10.4 million
  • Net income margin improved to 1.69% in the latest quarter
  • Current ratio of 1.72 indicates solid liquidity position
SRX Global Inc. is positioned in a rapidly evolving market, with a focus on AI technologies that are increasingly sought after across various industries. The company's recent financial performance reflects a growing revenue stream and a robust cash position, which may support future investments and operational enhancements. The positive trends in net income and liquidity ratios further indicate a potential for sustainable growth. As the demand for AI solutions continues to expand, SRX Global Inc. stands to benefit from its innovative offerings and strategic market positioning.
AI Generated • Aug 4, 2026

Industry

Food Products

Sector

Consumer Staples

Employees

21

CEO

Kent Cunningham, MBA

Website

www.srxhealth.com

Headquarters

North Palm Beach, FL 33408, US

SRXH Financials

Key Financial Metrics (TTM)

Gross Margin

32.49%

Operating Margin

-4.20%

Net Income Margin

108.05%

Return on Equity

-97.77%

Return on Capital

-233.73%

Return on Assets

-27.81%

Earnings Yield

100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$34.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

20.27M

Volume

1.95K

Avg. Volume

4.09M

Financials (TTM)

Gross Profit

-$12.16M

Operating Income

$1.57M

EBITDA

-$7.07M

Operating Cash Flow

$101.00K

Capital Expenditure

-$8.46M

Free Cash Flow

-$8.36M

Cash & ST Invst.

$49.69M

Total Debt

$0.00

Srx Global Performance Analysis

Srx Global annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 54,660,00018.8%
20232023-12-31USD 38,592,000-29.4%
20242024-12-31USD 34,975,000-9.4%
20252025-09-30USD 6,534,000-81.3%
Srx Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30-511.0%
Q12025-12-31106.0%
Q22026-03-3122.5%
Q32026-06-30-1.4%
Srx Global annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -3,536.07N/A
20232023-12-31USD -1,937.34-45.2%
20242024-12-31USD -6.24-99.7%
20252025-09-30USD -127.941950.5%
Srx Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30-39.2%
Q12025-12-3174.8%
Q22026-03-3191.8%
Q32026-06-3071.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$3.39M

-70.4%

Gross Profit

$904.00K

-44.2%

Gross Margin

26.65%

N/A

Market Cap

$34.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.86M

N/A

Employees

7

N/A

Net Income

-$4.14M

+72.6%

EBITDA

-$3.57M

+72.4%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$49.69M

+5348.2%

Total Debt

$0.00

-100.0%

Accounts Receivable

$8.57M

+5.2%

Inventory

$2.61M

-49.1%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-27.81%

N/A

Return on Invested Capital

1.10%

N/A

Free Cash Flow

-$956.00K

+94.1%

Operating Cash Flow

-$956.00K

+94.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MRKRMarker Therapeutics, Inc.
$1.33-2.92%
CLRBCellectar Biosciences, Inc.
$2.51-0.79%
SNSESensei Biotherapeutics, Inc.
$13.85-22.28%
BOLTBolt Biotherapeutics, Inc.
$3.98+4.19%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
WETOWetour Robotics
$5.48-0.04%
IBITiShares Bitcoin Trust
$44.67+0.02%
INTCIntel
$89.51+0.00%

Questions About SRXH

What is the current price of Srx Global?

Srx Global is trading at $1.68 per share.

What is the 52-week range for Srx Global?

Over the past 52 weeks, Srx Global has traded between $0.94 and $41.56.

How much debt does Srx Global have?

As of the most recent reporting period, Srx Global reported total debt of $0.00.

How much cash does Srx Global have on hand?

Srx Global reported $36.69M in cash and cash equivalents in its most recent financial results.

What is Srx Global’s dividend yield?

Srx Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services